Compare CEPU & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CEPU | PLSE |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2018 | 2016 |
| Metric | CEPU | PLSE |
|---|---|---|
| Price | $17.23 | $14.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $17.50 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 271.8K | 162.0K |
| Earning Date | 03-10-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $607,552,200.00 | $86,000.00 |
| Revenue This Year | $16.07 | N/A |
| Revenue Next Year | $15.36 | $1,002.94 |
| P/E Ratio | $13.08 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.43 | $12.56 |
| 52 Week High | $18.50 | $25.00 |
| Indicator | CEPU | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 54.49 |
| Support Level | $14.77 | $13.82 |
| Resistance Level | $15.88 | $15.34 |
| Average True Range (ATR) | 0.85 | 0.76 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 67.19 | 55.58 |
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.